Emerging evidence supports the opinion that PD-L1 engagement on cancer cells with its receptor, PD-1, on effector T cells is the major mechanism contributing to the exhaustion of tumor-infiltrating CD8+ T cells and subsequent tumor immune evasion. This evidence concerns the gene CD8A and cancer.